Alan Majchrowicz Photography

  • Home
  • Blog
  • Archive
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Facebook
  • Twitter
x

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
98 images found
twitterlinkedinfacebook

Loading ()...

  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24731.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24730.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24729.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24728.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24727.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24726.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24725.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24724.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24723.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24721.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24720.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24719.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24718.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24717.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24716.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24715.jpg
  • Three packaged syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24714.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24713.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24712.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24711.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24710.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24732.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24722.jpg
  • am_090821_24708.jpg
  • Cup of morning tea and daily medications.
    am_090821_24737.jpg
  • Cup of morning tea and daily medications.
    am_090821_24736.jpg
  • Cup of morning tea and daily medications.
    am_090821_24735.jpg
  • Cup of morning tea and daily medications.
    am_090821_24734.jpg
  • Cup of morning tea and daily medications.
    am_090821_24733.jpg
  • am_090821_24709.jpg
  • am_090821_24707.jpg
  • am_090821_24706.jpg
  • am_090821_24705.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13338.jpg
  • Helmcken Falls in winter, Wells Grey Provincial Park British Columbia Canada
    am_110217_42986.jpg
  • Helmcken Falls in winter, Wells Grey Provincial Park British Columbia canada
    am_010220_3158.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13346.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13352.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070727_13373.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070727_13372.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42993.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42990.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42988.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42984.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42983.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42981.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42978.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42973.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42971.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42970.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42968.jpg
  • Helmcken Falls in winter, Wells gray Provincial Park British Columbia Canada
    am_110217_42965.jpg
  • Helmcken Falls in winter, Wells Grey Provincial Park British Columbia canada
    am_010220_3157.jpg
  • Helmcken Falls in winter, Wells Grey Provincial Park British Columbia Canada
    am_010220_3156.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13357.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13354.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13344.jpg
  • Trophy Meadows, Wells Gray Provincial Park British Columbia Canada
    am_070726_13336.jpg
  • Winter dawn in the Cariboo Mountains British Columbia
    am_020115_3692_b.jpg
  • Snow covered trees in the Cariboo Mountains British Columbia
    am_020115_3690.jpg
  • Winter dawn in the Cariboo Mountains British Columbia
    am_020115_3692.jpg
  • Snow covered trees at dawn in the Cariboo Mountains British Columbia
    am_020115_3691.jpg
  • Red Well Trailhead into Coyote Gulch, Glen Canyon National Recreation Area Utah
    am_211027_76353.jpg
  • Red Well Trailhead into Coyote Gulch, Glen Canyon National Recreation Area Utah
    am_211027_76354.jpg
  • Red Well Trailhead into Coyote Gulch, Glen Canyon National Recreation Area Utah
    am_211027_76352.jpg
  • Helmcken Falls Wells Grey Provincial Park British Columbia Canada
    am_000620_2871.jpg
  • Cariboo Mountains in winter, Wells Grey Provincial Park British Columbia Canada
    am_020115_3683.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46835.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46831.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46830.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46829.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46828.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46825.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46822.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46819.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46817.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46816.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46814.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46813.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46812.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46810.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46808.jpg
  • Pumpjack at oil well on the Montana plains near the Rocky Mountain Front Ranges of Glacier National Park USA
    am_081016_21742.jpg
  • Pumpjack at oil well on the Montana plains near the Rocky Mountain Front Ranges of Glacier National Park USA
    am_081016_21740.jpg
  • Pumpjack at oil well on the Montana plains near the Rocky Mountain Front Ranges of Glacier National Park USA
    am_081016_21739.jpg
  • Pumpjack at oil well on the Montana plains near the Rocky Mountain Front Ranges of Glacier National Park USA
    am_081016_21738.jpg
  • Pumpjack at oil well on the Montana plains near the Rocky Mountain Front Ranges of Glacier National Park USA
    am_081016_21737.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46832.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46827.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46824.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46823.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46821.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46815.jpg
  • Multnomah Falls, one of the most well known scenic attractions in Oregon and the Pacific Northwest, Columbia River Gorge National Scenic Area Oregon
    am_111002_46811.jpg
  • Cariboo Mountains in winter, Wells Grey Provincial Park British Columbia Canada
    am_020115_3684.jpg
  • Helmcken Falls Wells grey provincial Park British Columbia Canada
    am_000620_2871h.jpg
  • Cariboo Mountains in winter, Wells Grey Provincial Park British Columbia Canada
    am_020115_3689.jpg
  • Cariboo Mountains in winter, Wells Grey Provincial Park British Columbia Canada
    am_020115_3685.jpg